A000100 Stock Overview
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for A000100 from our risk checks.
Yuhan Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩74,500.00 |
| 52 Week High | ₩84,190.48 |
| 52 Week Low | ₩52,285.71 |
| Beta | 0.48 |
| 1 Month Change | -3.75% |
| 3 Month Change | -0.80% |
| 1 Year Change | 33.26% |
| 3 Year Change | 36.46% |
| 5 Year Change | 91.31% |
| Change since IPO | 6,355.11% |
Recent News & Updates
Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 13
Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem
May 26Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly
May 13Recent updates
Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 13Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem
May 26Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly
May 13Yuhan Corporation's (KRX:000100) P/E Is Still On The Mark Following 26% Share Price Bounce
Mar 11Yuhan (KRX:000100) Has A Pretty Healthy Balance Sheet
May 01Are Investors Undervaluing Yuhan Corporation (KRX:000100) By 32%?
Apr 16Should You Or Shouldn't You: A Dividend Analysis on Yuhan Corporation (KRX:000100)
Mar 15Are Yuhan Corporation's (KRX:000100) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Feb 25Is There More To The Story Than Yuhan's (KRX:000100) Earnings Growth?
Feb 10
Does Yuhan (KRX:000100) Have A Healthy Balance Sheet?
Jan 28The Yuhan (KRX:000100) Share Price Has Gained 92% And Shareholders Are Hoping For More
Jan 13Is Yuhan Corporation (KRX:000100) Popular Amongst Institutions?
Dec 31Estimating The Fair Value Of Yuhan Corporation (KRX:000100)
Dec 18Is Yuhan Corporation's (KRX:000100) 0.6% Dividend Worth Your Time?
Dec 05Has Yuhan Corporation's (KRX:000100) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Nov 20Shareholder Returns
| A000100 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -5.0% | -4.5% | 1.1% |
| 1Y | 33.3% | 4.2% | 3.7% |
Return vs Industry: A000100 exceeded the KR Pharmaceuticals industry which returned 4.2% over the past year.
Return vs Market: A000100 exceeded the KR Market which returned 3.7% over the past year.
Price Volatility
| A000100 volatility | |
|---|---|
| A000100 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.2% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A000100 has not had significant price volatility in the past 3 months.
Volatility Over Time: A000100's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1926 | 1,999 | Wook-Je Cho | www.yuhan.co.kr |
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.
Yuhan Corporation Fundamentals Summary
| A000100 fundamental statistics | |
|---|---|
| Market cap | ₩5.58t |
| Earnings (TTM) | ₩124.47b |
| Revenue (TTM) | ₩1.86t |
44.9x
P/E Ratio3.0x
P/S RatioIs A000100 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000100 income statement (TTM) | |
|---|---|
| Revenue | ₩1.86t |
| Cost of Revenue | ₩1.30t |
| Gross Profit | ₩563.39b |
| Other Expenses | ₩438.92b |
| Earnings | ₩124.47b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.66k |
| Gross Margin | 30.28% |
| Net Profit Margin | 6.69% |
| Debt/Equity Ratio | 11.9% |
How did A000100 perform over the long term?
See historical performance and comparison